Hudson Bay Capital Management LP Maxcyte, Inc. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$5.26 - $10.84 $1.54 Million - $3.18 Million
-293,452 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$8.87 - $12.94 $2.49 Million - $3.64 Million
280,952 Added 2247.62%
293,452 $2.99 Million
Q3 2021

Nov 15, 2021
BUY
$12.21 - $17.2 $152,625 - $215,000
12,500 New
12,500 $153,000

Others Institutions Holding MXCT

# of Institutions
125
Shares Held
65.6M
Call Options Held
1K
Put Options Held
2K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $503M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email